戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ar to the hypermobility phenotype in classic Ehlers-Danlos syndrome.
2 association between conjunctiovochalasis and Ehlers-Danlos syndrome.
3 ations in human Cd7 that have been linked to Ehlers-Danlos syndrome.
4 are associated with the most severe forms of Ehlers-Danlos syndrome.
5 ishes the Loeys-Dietz syndrome from vascular Ehlers-Danlos syndrome.
6 lycans manifest several clinical features of Ehlers-Danlos syndrome.
7             Mutations in TNXB are a cause of Ehlers-Danlos syndrome.
8 erextensibility, similar to individuals with Ehlers-Danlos syndrome.
9 the diagnostic criteria for either Marfan or Ehlers-Danlos syndrome.
10 ty and fragility resembling certain types of Ehlers-Danlos syndrome.
11 od vessels, similar to patients with type IV Ehlers-Danlos syndrome.
12  V expression in the pathobiology in classic Ehlers-Danlos syndrome.
13 he human Col3a1 gene are associated with the Ehlers-Danlos syndrome, a connective tissue disorder tha
14 e have been implicated as a cause of type IV Ehlers-Danlos syndrome, a disease leading to aortic rupt
15 in-X deficiency in humans is associated with Ehlers-Danlos syndrome, a generalized connective tissue
16 yers in the pathogenesis of certain types of Ehlers-Danlos syndrome and other connective tissue disor
17 are involved in the human cartilage disorder Ehlers-Danlos Syndrome and other disorders associated wi
18  confirms a causative role for TNXB in human Ehlers-Danlos syndrome and suggests that tenascin-X is a
19 erlie the connective tissue disorder classic Ehlers-Danlos syndrome, and autoimmune responses against
20        Collagen V mutations underlie classic Ehlers-Danlos syndrome, and joint hypermobility is an im
21 hough unlikely to present with frank classic Ehlers-Danlos syndrome, are likely to have fragile conne
22 sulting in spondyloepiphyseal dysplasias and Ehlers-Danlos syndrome, as well as fibrillin defects ass
23                          However, no classic Ehlers-Danlos syndrome case has yet been associated with
24 n the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation def
25                                      Classic Ehlers-Danlos syndrome (cEDS) is characterized by fragil
26 or the COL5A2 gene underlie cases of classic Ehlers-Danlos syndrome, characterized by fragile, hypere
27 chalasis who was subsequently diagnosed with Ehlers Danlos Syndrome, Classic Type.
28 he chains of Type II collagen), and vascular Ehlers-Danlos syndrome (COL3A1 encoding the chains of Ty
29 atosparaxis in animals, and a subtype of the Ehlers-Danlos syndrome (dermatosparactic type or VIIC) i
30 S-2) cause dermatosparaxis in cattle and the Ehlers-Danlos syndrome (dermatosparactic type) in humans
31 sufficient collagen V mouse model of classic Ehlers Danlos syndrome (EDS) had decreased biomechanical
32 ) locus cosegregated with the gravis form of Ehlers-Danlos syndrome (EDS) (type I) in a three generat
33 phenotype similar to some of the subtypes of Ehlers-Danlos syndrome (EDS) and cutis laxa.
34 of type I collagen can give rise to forms of Ehlers-Danlos syndrome (EDS) because of partial or compl
35 e most commonly identified mutations causing Ehlers-Danlos syndrome (EDS) classic type result in hapl
36                                              Ehlers-Danlos syndrome (EDS) designates a heterogeneous
37                                              Ehlers-Danlos syndrome (EDS) is a genetically and pathog
38                                              Ehlers-Danlos syndrome (EDS) is a group of collagen diso
39                                              Ehlers-Danlos syndrome (EDS) is a heterogeneous group of
40                                     Vascular Ehlers-Danlos syndrome (EDS) is a rare connective tissue
41                                     Vascular Ehlers-Danlos syndrome (EDS) results from mutations in t
42                                              Ehlers-Danlos syndrome (EDS) type I (the classical varie
43                                     Vascular Ehlers-Danlos syndrome (EDS) type IV is the most severe
44                                              Ehlers-Danlos syndrome (EDS) type IV results from mutati
45                                              Ehlers-Danlos syndrome (EDS) types I and II, which compr
46                                        As in Ehlers-Danlos syndrome (EDS) VIIA/B, fibrils containing
47 type V collagen in the classical form of the Ehlers-Danlos syndrome (EDS), a heritable connective-tis
48  of FKBP22 leads to a kyphoscoliotic type of Ehlers-Danlos syndrome (EDS), and this type of EDS is cl
49 I procollagen result in the vascular form of Ehlers-Danlos syndrome (EDS), EDS type IV, if they alter
50 e been identified in some cases of classical Ehlers-Danlos syndrome (EDS), in which aberrant collagen
51 etal fragility, they have characteristics of Ehlers-Danlos syndrome (EDS).
52  disease in conjunction with the features of Ehlers-Danlos syndrome (EDS).
53 onnective tissue findings are typical of the Ehlers-Danlos syndrome (EDS).
54                    Because TNXB is the first Ehlers-Danlos syndrome gene that does not encode a fibri
55 tive tissue disorders, such as some forms of Ehlers-Danlos syndrome, have been associated with severe
56  electronic medical records of patients with Ehlers-Danlos Syndrome hypermobility type (HEDS), includ
57  diagnosed with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type (JHS/EDS-HT),
58 uals from a family of three generations with Ehlers-Danlos Syndrome II.
59 1 are known to be prevalent in patients with Ehlers-Danlos syndrome, kyphoscoliosis type (type VI [ED
60  and in 12 probands presenting with vascular Ehlers-Danlos syndrome (Loeys-Dietz syndrome type II).
61 senting with symptoms like those of vascular Ehlers-Danlos syndrome may be used to guide therapy, inc
62 /=50 years of age with Marfan syndrome, LDS, Ehlers-Danlos syndrome, or nonspecific connective tissue
63 ited connective tissue disorders, among them Ehlers-Danlos syndrome, osteogenesis imperfecta, Marfan
64                                  Periodontal Ehlers-Danlos syndrome (pEDS) is an autosomal-dominant d
65 fibril profiles resembled those seen in some Ehlers-Danlos Syndrome phenotypes.
66  cause the spondylocheiro dysplastic form of Ehlers-Danlos syndrome (SCD-EDS), a heritable connective
67 yndrome types 1, 2, and 2B; Marfan syndrome; Ehlers-Danlos syndrome type 4; and juvenile glaucoma.
68 ernias resembling symptoms of a mild form of Ehlers-Danlos syndrome type III.
69  index patients with biochemically confirmed Ehlers-Danlos syndrome type IV and 199 of their affected
70                                              Ehlers-Danlos syndrome type IV results from mutations in
71 ve the first and second major complications, Ehlers-Danlos syndrome type IV results in premature deat
72                                              Ehlers-Danlos syndrome type IV, the vascular type, resul
73 ovascular complications, Marfan syndrome and Ehlers-Danlos syndrome type IV.
74  proven to be a powerful diagnostic test for Ehlers-Danlos syndrome type IV.
75 diagnosis of a patient with the phenotype of Ehlers-Danlos syndrome type VI was confirmed biochemical
76 tissue disorders osteogenesis imperfecta and Ehlers-Danlos syndrome types VIIA and VIIB.
77                                     Vascular Ehlers-Danlos syndrome (VEDS) causes reduced life expect
78                     The vascular type of the Ehlers-Danlos syndrome (vEDS) is caused by dominant-nega
79  in the ADAMTS-2 gene in dermatosparaxis and Ehlers-Danlos syndrome VIIC show this enzyme to be respo
80 poor wound healing and wide scar morphology, Ehlers-Danlos syndrome was confirmed in the patient.
81 c overlap between this syndrome and vascular Ehlers-Danlos syndrome, we screened an additional cohort
82 ional cohort of 40 patients who had vascular Ehlers-Danlos syndrome without the characteristic type I

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。